IDH1 and glioma: In the CGGA dataset, we included PANoptotic score and clinical characteristics, such as age, WHO grade, IDH mutation, 1p/19q co-deletion, and MGMT promoter methylation in multivariate Cox regression analysis and found that PANoptotic score was an independent factor affecting the prognosis of glioma patients (Figure 5A).